INDO US BIOTECH Financial Statement Analysis
|
||
|
The Revenues of INDO US BIOTECH have increased by 23.36% YoY .
The Earnings Per Share (EPS) of INDO US BIOTECH has decreased by -42.94 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
INDO US BIOTECH Last 5 Annual Financial Results
[BOM: 541304]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹62 Cr | ₹50 Cr | ₹40 Cr | ₹40 Cr | ₹35 Cr |
| Expenses | ₹52 Cr | ₹43 Cr | ₹35 Cr | ₹36 Cr | ₹32 Cr |
| Operating Profit (Excl OI) | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr | ₹3.96 Cr | ₹3.42 Cr |
| Other Income | ₹0.02 Cr | ₹0.18 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.03 Cr |
| Interest | ₹1.20 Cr | ₹1.20 Cr | ₹1.18 Cr | ₹0.88 Cr | ₹0.40 Cr |
| Depreciation | ₹0.83 Cr | ₹0.42 Cr | ₹0.25 Cr | ₹0.21 Cr | ₹0.24 Cr |
| Profit Before Tax | ₹7.39 Cr | ₹5.49 Cr | ₹4.13 Cr | ₹2.86 Cr | ₹2.81 Cr |
| Profit After Tax | ₹7.24 Cr | ₹5.24 Cr | ₹5.10 Cr | ₹2.54 Cr | ₹2.09 Cr |
| Earnings Per Share (Rs) | ₹4.12 | ₹7.22 | ₹5.71 | ₹8.40 | ₹4.18 |
| PAT Margin (%) | 11.33 | 11.73 | 10.46 | 12.72 | 6.37 |
| ROE(%) | 14.08 | 15.51 | 17.34 | 26.87 | 16.74 |
| ROCE(%) | 14.42 | 14.62 | 15.86 | 18.30 | 16.65 |
| Total Debt/Equity(x) | 0.23 | 0.21 | 0.32 | 0.53 | 0.52 |
Key Financials |
||
| Market Cap | : | ₹ 422.4 Cr |
| Revenue (TTM) | : | ₹ 86.2 Cr |
| Net Profit(TTM) | : | ₹ 13.1 Cr |
| EPS (TTM) | : | ₹ 6.5 |
| P/E (TTM) | : | 32.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDO US BIOTECH | -2% | -13.8% | -11.3% |
| BOMBAY BURMAH TRADING CORPORATION | -11% | -7% | 13% |
| KAVERI SEED COMPANY | -1.8% | 3.7% | 40.3% |
| VENKYS (INDIA) | -4.7% | -3.7% | -4.5% |
| BOMBAY SUPER HYBRID SEEDS | -10.6% | 1% | -38.1% |
| TIERRA AGROTECH | -5% | -12.3% | -35.7% |
| NATH BIOGENES (INDIA) | -6.3% | -13.1% | -23.7% |
| MANGALAM SEEDS | -15.1% | -9.3% | -31.8% |
| SHREE OSWAL SEEDS AND CHEMICALS | -12.3% | -19% | -67.5% |
INDO US BIOTECH Revenues
[BOM: 541304]
| Y-o-Y | 23.36 % |
| 5 Yr CAGR | 14.85 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹62 Cr | 23.36 | |
| Mar2023 | ₹50 Cr | 24.86 | |
| Mar2022 | ₹40 Cr | 0.82 | |
| Mar2021 | ₹40 Cr | 12.03 | |
| Mar2020 | ₹35 Cr | - | |
INDO US BIOTECH Operating Profit
[BOM: 541304]
| Y-o-Y | 35.52 % |
| 5 Yr CAGR | 28.73 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹9.39 Cr | 35.52 | |
| Mar2023 | ₹6.93 Cr | 25.70 | |
| Mar2022 | ₹5.51 Cr | 39.10 | |
| Mar2021 | ₹3.96 Cr | 15.91 | |
| Mar2020 | ₹3.42 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 9.82 % |
| 5 Yr CAGR | 12.08 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 15.21% | 9.82 | |
| Mar2023 | 13.85% | 0.65 | |
| Mar2022 | 13.76% | 38.01 | |
| Mar2021 | 9.97% | 3.42 | |
| Mar2020 | 9.64% | - | |
INDO US BIOTECH Profit After Tax
[BOM: 541304]
| Y-o-Y | 38.25 % |
| 5 Yr CAGR | 36.46 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹7.24 Cr | 38.25 | |
| Mar2023 | ₹5.24 Cr | 2.73 | |
| Mar2022 | ₹5.10 Cr | 101.10 | |
| Mar2021 | ₹2.54 Cr | 21.41 | |
| Mar2020 | ₹2.09 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -3.41 % |
| 5 Yr CAGR | 15.48 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 11.33 % | -3.41 | |
| Mar2023 | 11.73 % | 12.14 | |
| Mar2022 | 10.46 % | -17.77 | |
| Mar2021 | 12.72 % | 99.69 | |
| Mar2020 | 6.37 % | - | |
INDO US BIOTECH Earnings Per Share (EPS)
[BOM: 541304]
| Y-o-Y | -42.94 % |
| 5 Yr CAGR | -0.36 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹4.12 | -42.94 | |
| Mar2023 | ₹7.22 | 26.44 | |
| Mar2022 | ₹5.71 | -32.02 | |
| Mar2021 | ₹8.40 | 100.96 | |
| Mar2020 | ₹4.18 | - | |
INDO US BIOTECH Return on Capital Employed (ROCE)
[BOM: 541304]
| Y-o-Y | -1.37 % |
| 5 Yr CAGR | -3.53 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 14.42% | -1.37 | |
| Mar2023 | 14.62% | -7.82 | |
| Mar2022 | 15.86% | -13.33 | |
| Mar2021 | 18.3% | 9.91 | |
| Mar2020 | 16.65% | - | |
INDO US BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹210.2 |
| Current MarketCap | : | ₹ 422.4 Cr |
| Updated EOD on | : | Feb 14,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -2% |
-13.8% |
-11.3% |
| SENSEX | -2.5% |
-1.4% |
6.1% |
INDO US BIOTECH related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about INDO US BIOTECH Financials
How the annual revenues of INDO US BIOTECH have changed ?
The Revenues of INDO US BIOTECH have increased by 23.36% YoY .
How the Earnings per Share (EPS) of INDO US BIOTECH have changed?
The Earnings Per Share (EPS) of INDO US BIOTECH has decreased by -42.94 % YoY .
Check out Intrinsic Value of Peers of INDO US BIOTECH
Compare Stock Analytics of Peers of INDO US BIOTECH
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs
